Sermonix Pharmaceuticals Announces Four Abstracts Accepted for Presentation at 2022 San Antonio…
COLUMBUS, Ohio, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative targeted therapeutics to specifically treat ESR1-mutated metastatic breast and…